Neogen [NEOG] vs Thermo Fisher [TMO] Detailed Stock Comparison

Neogen Corporation

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Neogen Corporation wins in 5 metrics, Thermo Fisher Scientific Inc. wins in 13 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Neogen Corporation Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) 865.00 25.84 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 0.98 3.31 Neogen Corporation
Debt-to-Equity Ratio 37.82 82.91 Neogen Corporation
PEG Ratio 14.79 2.29 Thermo Fisher Scientific Inc.
EV/EBITDA 33.05 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -69.94% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -1.56% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -25.57% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -0.61% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $-46.35M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 53.07% 22.27% Neogen Corporation
Price-to-Sales Ratio (TTM) 2.36 3.86 Neogen Corporation
Enterprise Value $2.69B $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 3.09 4.75 Neogen Corporation
Gross Profit Margin (TTM) 46.88% N/A N/A
Revenue per Share (TTM) $4 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-2.80 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 1.97 0.97 Thermo Fisher Scientific Inc.
Short % of Float 6.18% 1.22% Thermo Fisher Scientific Inc.

Neogen Corporation vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

NEOG
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Neogen Corporation0.69%-4.27%-3.74%-21.52%47.80%25.00%
Thermo Fisher Scientific Inc.-1.69%7.56%4.21%-5.21%-16.94%-18.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Neogen Corporation53.07%-51.54%-80.17%-53.16%-15.62%296.90%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: Neogen Corporation vs Thermo Fisher Scientific Inc.

MetricNEOGTMO
Market Information
Market Cap i$2.04B$174.55B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i3,110,7902,356,220
90 Day Avg. Volume i2,601,3132,071,517
Last Close$8.81$473.95
52 Week Range$4.53 - $11.43$385.46 - $643.99
% from 52W High-22.92%-26.40%
All-Time High$48.85 (Apr 26, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-81.97%-29.51%
Growth Metrics
Quarterly Revenue Growth-0.04%0.06%
Quarterly Earnings Growth-0.04%0.10%
Financial Health
Profit Margin (TTM) i-0.70%0.15%
Operating Margin (TTM) i-0.02%0.18%
Return on Equity (TTM) i-0.26%0.14%
Debt to Equity (MRQ) i37.8282.91
Cash & Liquidity
Book Value per Share (MRQ)$9.66$141.96
Cash per Share (MRQ)$0.74$8.75
Operating Cash Flow (TTM) i$69.44M$8.29B
Levered Free Cash Flow (TTM) i$19.47M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Neogen Corporation vs Thermo Fisher Scientific Inc.

MetricNEOG (Apr 24, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i865.0025.84
Forward P/E i32.1117.16
PEG Ratio i14.792.29
Price to Sales (TTM) i2.363.86
Price to Book (MRQ) i0.983.31
Market Capitalization
Market Capitalization i$2.04B$174.55B
Enterprise Value i$2.69B$214.76B
Enterprise Value Metrics
Enterprise to Revenue i3.094.75
Enterprise to EBITDA i33.0519.02
Risk & Other Metrics
Beta i1.970.97
Book Value per Share (MRQ) i$9.66$141.96

Financial Statements Comparison: Neogen Corporation vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNEOG (2025)TMO (2025)
Revenue/Sales i894.66M44.56B
Cost of Goods Sold i473.29M26.32B
COGS % of Revenue i52.9%59.1%
Gross Profit i421.38M18.24B
Gross Margin i47.1%40.9%
Research & Development i21.09M1.40B
Operating Income (EBIT) i-1.68M8.11B
Operating Margin i-0.2%18.2%
EBITDA i123.51M11.86B
EBITDA Margin i13.8%26.6%
Pre-Tax Income i-1.13B7.31B
Pre-Tax Income % of Revenue i-126.7%16.4%
Income Tax i-41.07M547.00M
Income Tax % of Revenue i-4.6%1.2%
Net Income (Profit) i-1.09B6.72B
Profit Margin i-122.1%15.1%

Balance Sheet & Liquidity Metrics

MetricNEOG (2025)TMO (2025)
Cash & Equivalents i129.00M9.85B
Total Current Assets i576.94M28.71B
Total Current Assets % of Revenue i64.5%64.4%
Total Current Liabilities i174.01M15.19B
Total Current Liabilities % of Revenue i19.4%34.1%
Long-Term Debt i874.81M35.85B
Long-Term Debt % of Revenue i97.8%80.5%
Total Shareholders Equity i2.07B53.54B
Retained Earnings i-536.42M59.16B
Retained Earnings % of Revenue i-60.0%132.8%
Property, Plant & Equipment i17.15M0

Cash Flow Statement Comparison

MetricNEOG (2025)TMO (2025)
Operating Cash Flow i-1.01B7.82B
Operating Cash Flow % of Revenue i-113.0%17.5%
Capital Expenditures i-99.52M-1.48B
Free Cash Flow i-46.35M6.29B
FCF Margin i-5.2%14.1%
Debt Repayment i-550.32M-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricNEOGTMO
Shares Short i10.07M4.54M
Short Ratio i4.092.38
Short % of Float i6.18%1.22%
Shares Outstanding i217.67M371.62M
Float Shares i216.51M371.07M
% Held by Insiders i0.94%0.17%
% Held by Institutions i106.92%95.23%
% Held by Public i-7.86%4.60%

Dividend Analysis & Yield Comparison: Neogen Corporation vs Thermo Fisher Scientific Inc.

MetricNEOGTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026